Apecotrep Shows 40% Proteinuria Reduction in Phase II FSGS Trial
Ingelheim, Germany | January 29, 2026 — Boehringer Ingelheim announced positive results from a 12-week Phase II clinical trial...
apecotrep
Advertisement
Advertisement
Advertisement
Ingelheim, Germany | January 29, 2026 — Boehringer Ingelheim announced positive results from a 12-week Phase II clinical trial...
Advertisement